In our study, we have considered RIS, CIS, and MS patients together within the IDD group, thus finding an age-adjusted AUC of CSF NfL of 0.87, in line with the above-mentioned previously reported AUC values. This evidence concerns the gene NEFL and in situ carcinoma.